Pao Group(OTC) PAOG

Current Price$0.00

Market Cap$382.00K

Since IPO (2007)-100%

5 Year-95%

1 Year+19,900%

1 Month+0%

Pao Group last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-07-24

Pao Group stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-33.33%	USD 0.00	2026-07-16
1 month	+0%	USD 0.00	2026-06-24
3 month	-33.33%	USD 0.00	2026-04-24
Year to date	-71.43%	USD 0.00	2025-12-31
1 year	+19,900%	USD 0.00	2025-07-24
3 year	+19,900%	USD 0.00	2023-07-17
5 year	-95%	USD 0.00	2021-07-23
Since inception	-100%	USD 760.87	2007-06-15

Pao Group Financials at a Glance

Market Cap

$382.00K

Revenue (TTM)

$0.00

Net Income (TTM)

-$117.22K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

13.69 (High)

Dividend

$0.00

Beta (Volatility)

13.69 (High)

Price

$0.00

Volume

721,650

Open

$0.00

Price

$0.00

Volume

721,650

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

13.69 (High)

Price

$0.00

Volume

721,650

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

PAOG News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pao Group

PAO Group, Inc. is a healthcare company based in Sandusky, Ohio, specializing in alternative patient care solutions. The company focuses on the development, distribution, and sale of high-quality medicinal cannabis products aimed at supporting individuals with chronic and terminal conditions.

Products and Services

Medicinal cannabis products for chronic conditions
Alternative patient care solutions through subsidiaries
Research and development in healthcare innovations

Growth Outlook

Expansion in the medicinal cannabis market is anticipated
Increasing demand for alternative healthcare solutions supports growth
Strategic partnerships may enhance product distribution

Financial Highlights

Recent quarterly net income of -$30,121 indicates ongoing challenges
Trailing twelve months show a negative P/E ratio of -10.03
Cash and cash equivalents increased to $575 in Q2 2024

PAO Group, Inc. operates in the medical care facilities industry, focusing on innovative healthcare solutions. The company has faced financial challenges, as indicated by its recent net income figures. However, the medicinal cannabis market is experiencing growth, which may provide opportunities for recovery and expansion. The increase in cash reserves in the latest quarter suggests a potential for improved liquidity, which could support future operations and strategic initiatives. Investors may find interest in the company's focus on alternative healthcare solutions, especially as demand continues to rise in this sector.

AI Generated • Jul 27, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

James Schramm

Website

www.pao.group

Headquarters

Sandusky, NE 44870, US

PAOG Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

3.43%

Return on Capital

N/A

Return on Assets

-12087.94%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$382.00K

Shares Outstanding

1.91B

Volume

721.65K

Avg. Volume

810.68K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$66.46K

EBITDA

$20.63K

Operating Cash Flow

$170.14K

Capital Expenditure

$0.00

Free Cash Flow

$170.14K

Cash & ST Invst.

$315.00

Total Debt

$639.95K

Pao Group Performance Analysis

Pao Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 0	N/A
2024	2024-12-31	USD 0	N/A
2025	2025-12-31	USD 0	N/A

Pao Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2023-12-31	N/A
Q1	2024-03-31	N/A
Q2	2024-06-30	N/A
Q1	2026-03-31	N/A

Pao Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.00	-50.0%
2023	2023-12-31	USD 0.00	N/A
2024	2024-12-31	USD 0.00	N/A
2025	2025-12-31	USD 0.00	N/A

Pao Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2023-12-31	-100.0%
Q1	2024-03-31	N/A
Q2	2024-06-30	N/A
Q1	2026-03-31	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$382.00K

N/A

Market Cap/Employee

$54.57K

N/A

Employees

N/A

Net Income

-$28.06K

-109.3%

EBITDA

-$16.50K

-105.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$315.00

-69.6%

Total Debt

$639.95K

+0.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$639.95K

+0.0%

Return on Assets

-120.88%

N/A

Return on Invested Capital

3.13%

N/A

Free Cash Flow

-$459.00

+89.2%

Operating Cash Flow

-$459.00

+89.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LCDXCaliber Imaging & Diagnostics, Inc.

LCDXCaliber Imaging & Diagnostics, Inc.$0.00+50.00%

ONSSOnassis Holdings Corp.

ONSSOnassis Holdings Corp.$0.00+49.25%

ANTHAnthera Pharmaceuticals, Inc.

ANTHAnthera Pharmaceuticals, Inc.$0.00+0.00%

BBLNFBabylon Holdings Limited

BBLNFBabylon Holdings Limited$0.00+0.00%

SVSOSheerVision, Inc.

SVSOSheerVision, Inc.$0.00+0.00%

OVITOncoVista Innovative Therapies, Inc.

OVITOncoVista Innovative Therapies, Inc.$0.00+0.00%

LPTILongport, Inc.

LPTILongport, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.24+0.10%

BMNRBitmine Immersion Technologies

BMNRBitmine Immersion Technologies$17.38+0.10%

SKHYSK Hynix

SKHYSK Hynix$141.20-0.09%

SKDDGraniteShares ETF Trust - GraniteShares 2x Short Sk Hynix Daily ETF

SKDDGraniteShares ETF Trust - GraniteShares 2x Short Sk Hynix Daily ETF$17.52+0.18%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$677.75-0.01%

NOKNokia

NOKNokia$8.99-0.01%

NVDANvidia

NVDANvidia$198.09-0.04%

Questions About PAOG

What is the current price of Pao Group?

Pao Group is trading at $0.00 per share.

What is the 52-week range for Pao Group?

Over the past 52 weeks, Pao Group has traded between $0.00 and $0.00.

How much debt does Pao Group have?

As of the most recent reporting period, Pao Group reported total debt of $639.95K.

How much cash does Pao Group have on hand?

Pao Group reported $315.00 in cash and cash equivalents in its most recent financial results.

What is Pao Group’s dividend yield?

Pao Group does not currently have a dividend yield.

Pao Group(OTC) PAOG

Pao Group Financials at a Glance

PAOG News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Pao Group

PAOG Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Pao Group Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PAOG

What is the current price of Pao Group?

What is the 52-week range for Pao Group?

How much debt does Pao Group have?

How much cash does Pao Group have on hand?

What is Pao Group’s dividend yield?

Premium Investing Services